Identification of neoantigens in oesophageal adenocarcinoma-Reference-Cited by-同舟云学术

Identification of neoantigens in oesophageal adenocarcinoma

Published:2022-10-19 Issue:3 Volume:168 Page:420-431
ISSN:0019-2805
Container-title:Immunology
language:en
Short-container-title:Immunology

Author:

Nicholas Ben¹²^ORCID,Bailey Alistair¹²^ORCID,McCann Katy J.³^ORCID,Wood Oliver³,Walker Robert C.³^ORCID,Parker Robert⁴^ORCID,Ternette Nicola⁴^ORCID,Elliott Tim²⁵^ORCID,Underwood Tim J.³^ORCID,Johnson Peter⁶^ORCID,Skipp Paul¹^ORCID

Affiliation:

1. Centre for Proteomic Research, Biological Sciences and Institute for Life Sciences University of Southampton Southampton Hampshire UK

2. Centre for Cancer Immunology and Institute for Life Sciences, Faculty of Medicine University of Southampton Southampton Hampshire UK

3. School of Cancer Sciences, Faculty of Medicine University of Southampton Southampton Hampshire UK

4. Centre for Cellular and Molecular Physiology, Nuffield Department of Medicine University of Oxford Oxford UK

5. Centre for Immuno‐oncology, Nuffield Department of Medicine University of Oxford UK

6. Cancer Research UK Clinical Centre University of Southampton Southampton Hampshire UK

Funder

Biotechnology and Biological Sciences Research Council

Cancer Research UK

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imm.13578

Reference49 articles.

1. Oesophageal cancer

2. A compendium of mutational cancer driver genes

3. Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance

4. The landscape of selection in 551 esophageal adenocarcinomas defines genomic biomarkers for the clinic

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population dynamics is a cancer driver;Carcinogenesis;2024-06-06

2. Targeting Tumor Heterogeneity with Neoantigen-Based Cancer Vaccines;Cancer Research;2023-12-06

3. Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges;Biomarker Research;2023-12-01

4. TOFIMS mass spectrometry-based immunopeptidomics refines tumor antigen identification;Nature Communications;2023-11-17

5. Game of Omes: ribosome profiling expands the MHC-I immunopeptidome;Current Opinion in Immunology;2023-08